WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H406301
CAS#: 160141-09-3
Description: L-744832, also known as L-744,832, is a potent Farnesyltransferase inhibitor with potential anticancer activity.
Hodoodo Cat#: H406301
Name: L-744832
CAS#: 160141-09-3
Chemical Formula: C26H45N3O6S2
Exact Mass: 559.28
Molecular Weight: 559.782
Elemental Analysis: C, 55.79; H, 8.10; N, 7.51; O, 17.15; S, 11.46
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: L744832; L 744832; L-744832
IUPAC/Chemical Name: (S)-isopropyl 2-((S)-2-(((2S,3S)-2-(((R)-2-amino-3-mercaptopropyl)amino)-3-methylpentyl)oxy)-3-phenylpropanamido)-4-(methylsulfonyl)butanoate
InChi Key: PGOKBMWPBDRDGN-IBXSQZDTSA-N
InChi Code: InChI=1S/C26H45N3O6S2/c1-6-19(4)23(28-15-21(27)17-36)16-34-24(14-20-10-8-7-9-11-20)25(30)29-22(12-13-37(5,32)33)26(31)35-18(2)3/h7-11,18-19,21-24,28,36H,6,12-17,27H2,1-5H3,(H,29,30)/t19-,21+,22-,23+,24-/m0/s1
SMILES Code: O=C(OC(C)C)[C@@H](NC([C@@H](OC[C@@H](NC[C@@H](N)CS)[C@@H](C)CC)CC1=CC=CC=C1)=O)CCS(=O)(C)=O
Appearance: Solid powder
Purity: >98%
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO, not in water
Shelf Life: >5 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 559.78 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Spindler SR, Li R, Dhahbi JM, Yamakawa A, Mote P, Bodmer R, Ocorr K, Williams
RT, Wang Y, Ablao KP. Statin treatment increases lifespan and improves cardiac
health in Drosophila by decreasing specific protein prenylation. PLoS One.
2012;7(6):e39581. doi: 10.1371/journal.pone.0039581. Epub 2012 Jun 21. PubMed
PMID: 22737247; PubMed Central PMCID: PMC3380867.
2: Murphy LA, Moore T, Nesnow S. Propiconazole-enhanced hepatic cell
proliferation is associated with dysregulation of the cholesterol biosynthesis
pathway leading to activation of Erk1/2 through Ras farnesylation. Toxicol Appl
Pharmacol. 2012 Apr 15;260(2):146-54. doi: 10.1016/j.taap.2012.02.003. Epub 2012
Feb 14. PubMed PMID: 22361350.